With respect to the relationship between IER3 alterations and total OS of HCC patients (Fig. 6B), the OS rate of the IER3 genetic alteration group was not much different from that of the non-genetic alteration group; however, this result was not statistically significant. This evidence concerns the gene IER3 and hepatocellular carcinoma.